Food and Drug Regulations, C.R.C., c. 870

Section C.03.311

Cite as Food and Drug Regulations, C.R.C., c. 870, s. C.03.311 · current to June 17, 2026 · regulation last amended June 17, 2026

Statute Watch

Get an alert when a bill in Parliament would change this section, and every time it moves.

The text

A sponsor shall ensure that each study is conducted in accordance with good clinical practices and that (a) the study is scientifically sound and clearly described in its protocol; (b) the study is conducted, and the study drug is used, in accordance with the protocol and with these Regulations; (c) systems and procedures are implemented that assure the quality of every aspect of the study; (d) at each study site, there is only one qualified investigator; (e) at each study site, medical care and medical decisions, in respect of the study, are under the supervision of the qualified investigator; (f) each individual who is involved in the conduct of the study is qualified by their education, training and experience to perform their respective tasks; (g) before a study subject participates in the study, a copy of their signed consent form is included in the records for the study; (h) the requirements respecting information and records set out in section C.03.315 are met; and (i) the study drug is manufactured, handled and stored in accordance with Division 2, other than sections C.02.019, C.02.025 and C.02.026.
Read the Food and Drug Regulations on the Justice Laws Website ↗

Made under Food and Drugs Act, R.S.C. 1985, c. F-27.

Bills in Parliament that would change this section 0

No bill we hold would amend or repeal this section.